Publisher
Springer Berlin Heidelberg
Reference16 articles.
1. Awni WM, Cavanaugh JH, Braeckman RA, Chu SY, Patterson KJ, Machinist JM, Granneman GR (1995) The effects of mild or moderate hepatic impairment (cirrhosis) on the pharmacokinetics of zileuton. Clin Pharmacokinet 29(suppl 2):49–61
2. Benet LZ, Hoener B-A (2002) Commentary: changes in plasma protein binding have little clinical significance. Clin Pharm Ther 71:115–121
3. De Smet R, Van Kaer J, Liebich H, Lesaffer G, Verstraete A, Dhondt A, Duym P, Lameire N, Vanholder R (2001) Heparin-induced release of protein-bound solutes during hemodialysis is an in vitro artifact. Clin Chem 47(5):901–909
4. EMEA CHMP (2004) Note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with impaired renal function, CPMP/EWP/225/02, December 2004.
5. EMEA CHMP (2005) Guideline on the evaluation of the pharmacokinetics of medicinal products in patients with impaired hepatic function, CPMP/EWP/2339/02, August 2005
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献